*)-1-[2,3- Search Results


anti myosin heavy chain mhc antibody  (Developmental Studies Hybridoma Bank)
95
Developmental Studies Hybridoma Bank anti myosin heavy chain mhc antibody
Anti Myosin Heavy Chain Mhc Antibody, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%2A%29-1-%5B2%2C3-/pm42087225-75-4-10?v=Developmental+Studies+Hybridoma+Bank
Average 95 stars, based on 1 article reviews
anti myosin heavy chain mhc antibody - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
rf splitter  (Mini-Circuits)
96
Mini-Circuits rf splitter
Rf Splitter, supplied by Mini-Circuits, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%2A%29-1-%5B2%2C3-/arxiv__2403__03417-72-28-31?v=Mini-Circuits
Average 96 stars, based on 1 article reviews
rf splitter - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
methoxy 3 pyridinyl methylene  (Pfizer Inc)
86
Pfizer Inc methoxy 3 pyridinyl methylene
Methoxy 3 Pyridinyl Methylene, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%2A%29-1-%5B2%2C3-/us12419876-48-9-14?v=Pfizer+Inc
Average 86 stars, based on 1 article reviews
methoxy 3 pyridinyl methylene - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
antibodies against hcv ns5a ab13833  (Danaher Inc)
99
Danaher Inc antibodies against hcv ns5a ab13833
Assays with HCV genotype 3a replicon. ( A ) G418 resistant HCV-3a replicon expressing Huh7.5 cells were treated with indicated compounds for 48 h and the firefly luciferase activity was plotted as relative luciferase units (RLU). DMSO treated HCV-3a replicon expressing Huh 7.5 cells was taken as 100%. ( B ) The toxicity of these compounds in the replicon expressing cells was measured using WST-1 assay reagent. The values are depicted as percentages with the DMSO treated cells taken as 100%. ( C ) The replicon expressing cells were treated with varying concentrations of 66E2 and relative luciferase unit is plotted against the concentration of 66E2. EC 50 is the compound concentration that inhibits 50% of viral replication (RLU). ( D ) Huh7.5 cells were treated with indicated concentrations of 66E2 and cytotoxicity determined using WST-1 assay reagent. The values are plotted as percentages with the DMSO treated cells taken as 100%. CC 50 is the compound concentration that produces 50% of cytotoxicity. ( E ) Western blot analysis. Replicon expressing Huh7.5 cells were treated with different concentrations of 66E2 and CMC for 48 hours and expression of <t>NS5A</t> monitored using anti NS5A antibody. Expression of GAPDH was determined for loading control. ( F ) Reverse-transcriptase quantitative PCR analysis was performed to determine the levels of positive and negative sense HCV-3a RNA upon treatment with 66E2 and CMC at 5 μM for 48 h. The % mean is shown above the bars and the error bars are standard deviations. All the assays in the figure were performed in triplicates and results presented are representative of at least three independent assays.
Antibodies Against Hcv Ns5a Ab13833, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%2A%29-1-%5B2%2C3-/pmc05517564-235-0-12?v=Danaher+Inc
Average 99 stars, based on 1 article reviews
antibodies against hcv ns5a ab13833 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
monoclonal mouse anti-tgf  (R&D Systems)
94
R&D Systems monoclonal mouse anti-tgf
Assays with HCV genotype 3a replicon. ( A ) G418 resistant HCV-3a replicon expressing Huh7.5 cells were treated with indicated compounds for 48 h and the firefly luciferase activity was plotted as relative luciferase units (RLU). DMSO treated HCV-3a replicon expressing Huh 7.5 cells was taken as 100%. ( B ) The toxicity of these compounds in the replicon expressing cells was measured using WST-1 assay reagent. The values are depicted as percentages with the DMSO treated cells taken as 100%. ( C ) The replicon expressing cells were treated with varying concentrations of 66E2 and relative luciferase unit is plotted against the concentration of 66E2. EC 50 is the compound concentration that inhibits 50% of viral replication (RLU). ( D ) Huh7.5 cells were treated with indicated concentrations of 66E2 and cytotoxicity determined using WST-1 assay reagent. The values are plotted as percentages with the DMSO treated cells taken as 100%. CC 50 is the compound concentration that produces 50% of cytotoxicity. ( E ) Western blot analysis. Replicon expressing Huh7.5 cells were treated with different concentrations of 66E2 and CMC for 48 hours and expression of <t>NS5A</t> monitored using anti NS5A antibody. Expression of GAPDH was determined for loading control. ( F ) Reverse-transcriptase quantitative PCR analysis was performed to determine the levels of positive and negative sense HCV-3a RNA upon treatment with 66E2 and CMC at 5 μM for 48 h. The % mean is shown above the bars and the error bars are standard deviations. All the assays in the figure were performed in triplicates and results presented are representative of at least three independent assays.
Monoclonal Mouse Anti Tgf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%2A%29-1-%5B2%2C3-/10__1523_slash_jneurosci__23___12___05178__2003-46-2-16?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
monoclonal mouse anti-tgf - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
low pass filters  (Mini-Circuits)
95
Mini-Circuits low pass filters
Assays with HCV genotype 3a replicon. ( A ) G418 resistant HCV-3a replicon expressing Huh7.5 cells were treated with indicated compounds for 48 h and the firefly luciferase activity was plotted as relative luciferase units (RLU). DMSO treated HCV-3a replicon expressing Huh 7.5 cells was taken as 100%. ( B ) The toxicity of these compounds in the replicon expressing cells was measured using WST-1 assay reagent. The values are depicted as percentages with the DMSO treated cells taken as 100%. ( C ) The replicon expressing cells were treated with varying concentrations of 66E2 and relative luciferase unit is plotted against the concentration of 66E2. EC 50 is the compound concentration that inhibits 50% of viral replication (RLU). ( D ) Huh7.5 cells were treated with indicated concentrations of 66E2 and cytotoxicity determined using WST-1 assay reagent. The values are plotted as percentages with the DMSO treated cells taken as 100%. CC 50 is the compound concentration that produces 50% of cytotoxicity. ( E ) Western blot analysis. Replicon expressing Huh7.5 cells were treated with different concentrations of 66E2 and CMC for 48 hours and expression of <t>NS5A</t> monitored using anti NS5A antibody. Expression of GAPDH was determined for loading control. ( F ) Reverse-transcriptase quantitative PCR analysis was performed to determine the levels of positive and negative sense HCV-3a RNA upon treatment with 66E2 and CMC at 5 μM for 48 h. The % mean is shown above the bars and the error bars are standard deviations. All the assays in the figure were performed in triplicates and results presented are representative of at least three independent assays.
Low Pass Filters, supplied by Mini-Circuits, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%2A%29-1-%5B2%2C3-/10__1117_slash_1__oe__58__6__064101-56-13-17?v=Mini-Circuits
Average 95 stars, based on 1 article reviews
low pass filters - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
catalyst  (BOC Sciences)
94
BOC Sciences catalyst
Assays with HCV genotype 3a replicon. ( A ) G418 resistant HCV-3a replicon expressing Huh7.5 cells were treated with indicated compounds for 48 h and the firefly luciferase activity was plotted as relative luciferase units (RLU). DMSO treated HCV-3a replicon expressing Huh 7.5 cells was taken as 100%. ( B ) The toxicity of these compounds in the replicon expressing cells was measured using WST-1 assay reagent. The values are depicted as percentages with the DMSO treated cells taken as 100%. ( C ) The replicon expressing cells were treated with varying concentrations of 66E2 and relative luciferase unit is plotted against the concentration of 66E2. EC 50 is the compound concentration that inhibits 50% of viral replication (RLU). ( D ) Huh7.5 cells were treated with indicated concentrations of 66E2 and cytotoxicity determined using WST-1 assay reagent. The values are plotted as percentages with the DMSO treated cells taken as 100%. CC 50 is the compound concentration that produces 50% of cytotoxicity. ( E ) Western blot analysis. Replicon expressing Huh7.5 cells were treated with different concentrations of 66E2 and CMC for 48 hours and expression of <t>NS5A</t> monitored using anti NS5A antibody. Expression of GAPDH was determined for loading control. ( F ) Reverse-transcriptase quantitative PCR analysis was performed to determine the levels of positive and negative sense HCV-3a RNA upon treatment with 66E2 and CMC at 5 μM for 48 h. The % mean is shown above the bars and the error bars are standard deviations. All the assays in the figure were performed in triplicates and results presented are representative of at least three independent assays.
Catalyst, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%2A%29-1-%5B2%2C3-/us12516141-489-1-14?v=BOC+Sciences
Average 94 stars, based on 1 article reviews
catalyst - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
anti tgf β1 2 3 ab  (R&D Systems)
94
R&D Systems anti tgf β1 2 3 ab
Assays with HCV genotype 3a replicon. ( A ) G418 resistant HCV-3a replicon expressing Huh7.5 cells were treated with indicated compounds for 48 h and the firefly luciferase activity was plotted as relative luciferase units (RLU). DMSO treated HCV-3a replicon expressing Huh 7.5 cells was taken as 100%. ( B ) The toxicity of these compounds in the replicon expressing cells was measured using WST-1 assay reagent. The values are depicted as percentages with the DMSO treated cells taken as 100%. ( C ) The replicon expressing cells were treated with varying concentrations of 66E2 and relative luciferase unit is plotted against the concentration of 66E2. EC 50 is the compound concentration that inhibits 50% of viral replication (RLU). ( D ) Huh7.5 cells were treated with indicated concentrations of 66E2 and cytotoxicity determined using WST-1 assay reagent. The values are plotted as percentages with the DMSO treated cells taken as 100%. CC 50 is the compound concentration that produces 50% of cytotoxicity. ( E ) Western blot analysis. Replicon expressing Huh7.5 cells were treated with different concentrations of 66E2 and CMC for 48 hours and expression of <t>NS5A</t> monitored using anti NS5A antibody. Expression of GAPDH was determined for loading control. ( F ) Reverse-transcriptase quantitative PCR analysis was performed to determine the levels of positive and negative sense HCV-3a RNA upon treatment with 66E2 and CMC at 5 μM for 48 h. The % mean is shown above the bars and the error bars are standard deviations. All the assays in the figure were performed in triplicates and results presented are representative of at least three independent assays.
Anti Tgf β1 2 3 Ab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%2A%29-1-%5B2%2C3-/pm32073751-55-43-46?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
anti tgf β1 2 3 ab - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
1 2 3 4 tetrahydroisoquinoline  (Thermo Fisher)
94
Thermo Fisher 1 2 3 4 tetrahydroisoquinoline
Assays with HCV genotype 3a replicon. ( A ) G418 resistant HCV-3a replicon expressing Huh7.5 cells were treated with indicated compounds for 48 h and the firefly luciferase activity was plotted as relative luciferase units (RLU). DMSO treated HCV-3a replicon expressing Huh 7.5 cells was taken as 100%. ( B ) The toxicity of these compounds in the replicon expressing cells was measured using WST-1 assay reagent. The values are depicted as percentages with the DMSO treated cells taken as 100%. ( C ) The replicon expressing cells were treated with varying concentrations of 66E2 and relative luciferase unit is plotted against the concentration of 66E2. EC 50 is the compound concentration that inhibits 50% of viral replication (RLU). ( D ) Huh7.5 cells were treated with indicated concentrations of 66E2 and cytotoxicity determined using WST-1 assay reagent. The values are plotted as percentages with the DMSO treated cells taken as 100%. CC 50 is the compound concentration that produces 50% of cytotoxicity. ( E ) Western blot analysis. Replicon expressing Huh7.5 cells were treated with different concentrations of 66E2 and CMC for 48 hours and expression of <t>NS5A</t> monitored using anti NS5A antibody. Expression of GAPDH was determined for loading control. ( F ) Reverse-transcriptase quantitative PCR analysis was performed to determine the levels of positive and negative sense HCV-3a RNA upon treatment with 66E2 and CMC at 5 μM for 48 h. The % mean is shown above the bars and the error bars are standard deviations. All the assays in the figure were performed in triplicates and results presented are representative of at least three independent assays.
1 2 3 4 Tetrahydroisoquinoline, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%2A%29-1-%5B2%2C3-/us10683269-1261-23-29?v=Thermo+Fisher
Average 94 stars, based on 1 article reviews
1 2 3 4 tetrahydroisoquinoline - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
anti pkm2  (Proteintech)
96
Proteintech anti pkm2
Assays with HCV genotype 3a replicon. ( A ) G418 resistant HCV-3a replicon expressing Huh7.5 cells were treated with indicated compounds for 48 h and the firefly luciferase activity was plotted as relative luciferase units (RLU). DMSO treated HCV-3a replicon expressing Huh 7.5 cells was taken as 100%. ( B ) The toxicity of these compounds in the replicon expressing cells was measured using WST-1 assay reagent. The values are depicted as percentages with the DMSO treated cells taken as 100%. ( C ) The replicon expressing cells were treated with varying concentrations of 66E2 and relative luciferase unit is plotted against the concentration of 66E2. EC 50 is the compound concentration that inhibits 50% of viral replication (RLU). ( D ) Huh7.5 cells were treated with indicated concentrations of 66E2 and cytotoxicity determined using WST-1 assay reagent. The values are plotted as percentages with the DMSO treated cells taken as 100%. CC 50 is the compound concentration that produces 50% of cytotoxicity. ( E ) Western blot analysis. Replicon expressing Huh7.5 cells were treated with different concentrations of 66E2 and CMC for 48 hours and expression of <t>NS5A</t> monitored using anti NS5A antibody. Expression of GAPDH was determined for loading control. ( F ) Reverse-transcriptase quantitative PCR analysis was performed to determine the levels of positive and negative sense HCV-3a RNA upon treatment with 66E2 and CMC at 5 μM for 48 h. The % mean is shown above the bars and the error bars are standard deviations. All the assays in the figure were performed in triplicates and results presented are representative of at least three independent assays.
Anti Pkm2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%2A%29-1-%5B2%2C3-/pm41576522-74-67-70?v=Proteintech
Average 96 stars, based on 1 article reviews
anti pkm2 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
anti plc β2  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology anti plc β2
Assays with HCV genotype 3a replicon. ( A ) G418 resistant HCV-3a replicon expressing Huh7.5 cells were treated with indicated compounds for 48 h and the firefly luciferase activity was plotted as relative luciferase units (RLU). DMSO treated HCV-3a replicon expressing Huh 7.5 cells was taken as 100%. ( B ) The toxicity of these compounds in the replicon expressing cells was measured using WST-1 assay reagent. The values are depicted as percentages with the DMSO treated cells taken as 100%. ( C ) The replicon expressing cells were treated with varying concentrations of 66E2 and relative luciferase unit is plotted against the concentration of 66E2. EC 50 is the compound concentration that inhibits 50% of viral replication (RLU). ( D ) Huh7.5 cells were treated with indicated concentrations of 66E2 and cytotoxicity determined using WST-1 assay reagent. The values are plotted as percentages with the DMSO treated cells taken as 100%. CC 50 is the compound concentration that produces 50% of cytotoxicity. ( E ) Western blot analysis. Replicon expressing Huh7.5 cells were treated with different concentrations of 66E2 and CMC for 48 hours and expression of <t>NS5A</t> monitored using anti NS5A antibody. Expression of GAPDH was determined for loading control. ( F ) Reverse-transcriptase quantitative PCR analysis was performed to determine the levels of positive and negative sense HCV-3a RNA upon treatment with 66E2 and CMC at 5 μM for 48 h. The % mean is shown above the bars and the error bars are standard deviations. All the assays in the figure were performed in triplicates and results presented are representative of at least three independent assays.
Anti Plc β2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%2A%29-1-%5B2%2C3-/pmc05584040-49-24-26?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
anti plc β2 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
putrescine d8  (Toronto Research Chemicals)
92
Toronto Research Chemicals putrescine d8
Assays with HCV genotype 3a replicon. ( A ) G418 resistant HCV-3a replicon expressing Huh7.5 cells were treated with indicated compounds for 48 h and the firefly luciferase activity was plotted as relative luciferase units (RLU). DMSO treated HCV-3a replicon expressing Huh 7.5 cells was taken as 100%. ( B ) The toxicity of these compounds in the replicon expressing cells was measured using WST-1 assay reagent. The values are depicted as percentages with the DMSO treated cells taken as 100%. ( C ) The replicon expressing cells were treated with varying concentrations of 66E2 and relative luciferase unit is plotted against the concentration of 66E2. EC 50 is the compound concentration that inhibits 50% of viral replication (RLU). ( D ) Huh7.5 cells were treated with indicated concentrations of 66E2 and cytotoxicity determined using WST-1 assay reagent. The values are plotted as percentages with the DMSO treated cells taken as 100%. CC 50 is the compound concentration that produces 50% of cytotoxicity. ( E ) Western blot analysis. Replicon expressing Huh7.5 cells were treated with different concentrations of 66E2 and CMC for 48 hours and expression of <t>NS5A</t> monitored using anti NS5A antibody. Expression of GAPDH was determined for loading control. ( F ) Reverse-transcriptase quantitative PCR analysis was performed to determine the levels of positive and negative sense HCV-3a RNA upon treatment with 66E2 and CMC at 5 μM for 48 h. The % mean is shown above the bars and the error bars are standard deviations. All the assays in the figure were performed in triplicates and results presented are representative of at least three independent assays.
Putrescine D8, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/%2A%29-1-%5B2%2C3-/pmc07481292-45-10-19?v=Toronto+Research+Chemicals
Average 92 stars, based on 1 article reviews
putrescine d8 - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

Image Search Results


Assays with HCV genotype 3a replicon. ( A ) G418 resistant HCV-3a replicon expressing Huh7.5 cells were treated with indicated compounds for 48 h and the firefly luciferase activity was plotted as relative luciferase units (RLU). DMSO treated HCV-3a replicon expressing Huh 7.5 cells was taken as 100%. ( B ) The toxicity of these compounds in the replicon expressing cells was measured using WST-1 assay reagent. The values are depicted as percentages with the DMSO treated cells taken as 100%. ( C ) The replicon expressing cells were treated with varying concentrations of 66E2 and relative luciferase unit is plotted against the concentration of 66E2. EC 50 is the compound concentration that inhibits 50% of viral replication (RLU). ( D ) Huh7.5 cells were treated with indicated concentrations of 66E2 and cytotoxicity determined using WST-1 assay reagent. The values are plotted as percentages with the DMSO treated cells taken as 100%. CC 50 is the compound concentration that produces 50% of cytotoxicity. ( E ) Western blot analysis. Replicon expressing Huh7.5 cells were treated with different concentrations of 66E2 and CMC for 48 hours and expression of NS5A monitored using anti NS5A antibody. Expression of GAPDH was determined for loading control. ( F ) Reverse-transcriptase quantitative PCR analysis was performed to determine the levels of positive and negative sense HCV-3a RNA upon treatment with 66E2 and CMC at 5 μM for 48 h. The % mean is shown above the bars and the error bars are standard deviations. All the assays in the figure were performed in triplicates and results presented are representative of at least three independent assays.

Journal: Scientific Reports

Article Title: A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound

doi: 10.1038/s41598-017-04449-3

Figure Lengend Snippet: Assays with HCV genotype 3a replicon. ( A ) G418 resistant HCV-3a replicon expressing Huh7.5 cells were treated with indicated compounds for 48 h and the firefly luciferase activity was plotted as relative luciferase units (RLU). DMSO treated HCV-3a replicon expressing Huh 7.5 cells was taken as 100%. ( B ) The toxicity of these compounds in the replicon expressing cells was measured using WST-1 assay reagent. The values are depicted as percentages with the DMSO treated cells taken as 100%. ( C ) The replicon expressing cells were treated with varying concentrations of 66E2 and relative luciferase unit is plotted against the concentration of 66E2. EC 50 is the compound concentration that inhibits 50% of viral replication (RLU). ( D ) Huh7.5 cells were treated with indicated concentrations of 66E2 and cytotoxicity determined using WST-1 assay reagent. The values are plotted as percentages with the DMSO treated cells taken as 100%. CC 50 is the compound concentration that produces 50% of cytotoxicity. ( E ) Western blot analysis. Replicon expressing Huh7.5 cells were treated with different concentrations of 66E2 and CMC for 48 hours and expression of NS5A monitored using anti NS5A antibody. Expression of GAPDH was determined for loading control. ( F ) Reverse-transcriptase quantitative PCR analysis was performed to determine the levels of positive and negative sense HCV-3a RNA upon treatment with 66E2 and CMC at 5 μM for 48 h. The % mean is shown above the bars and the error bars are standard deviations. All the assays in the figure were performed in triplicates and results presented are representative of at least three independent assays.

Article Snippet: Antibodies against HCV NS5A (ab13833) and DENV (ab26837 and ab9202) were from Abcam and anti GAPDH was purchased from Santa Cruz Biotechnology (USA).

Techniques: Expressing, Luciferase, Activity Assay, WST-1 Assay, Concentration Assay, Western Blot, Control, Reverse Transcription, Real-time Polymerase Chain Reaction